Amira Khater/LinkedIn
Feb 23, 2026, 15:16
Amira Khater: Key Updates on Pulmonary Embolism Management from AHA and ACC Guidelines
Amira Khater, Clinical Pharmacy Specialist at Sentara Healthcare, shared on LinkedIn:
“The AHA and ACC just released their first-ever joint guideline on acute pulmonary embolism, bringing clearer structure to how we diagnose and manage PE.
A few key updates that stood out to me:
- A new A–E classification system to better define PE severity and guide treatment
- DOACs remain first-line for most patients needing anticoagulation
- Advanced therapies like thrombolysis are reserved for higher-risk patients with clinical deterioration
- Greater emphasis on risk stratification and follow-up care
This is an important step toward more consistent, risk-based care—and highlights the ongoing role of the multidisciplinary team in improving outcomes for patients with PE.”
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation